Showing results (231-240 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|April 20, 1999
High yield purification and characterization of engineered human P450 1A2 and generation of immuno-inhibitor antibodiesB Louërat-Oriou, J P Flinois, P H Beaune, et al.Pharmacogenetics|September 30, 2003
Pharmacogenetic aspects of the use of oral contraceptives and the risk of thrombosisIda Martinelli, Tullia Battaglioli, Pier Mannuccio MannucciPharmacogenetics|September 30, 2003
Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6Julia Kirchheiner, Christian Klein, Ingolf Meineke, et al.Pharmacogenetics|December 4, 2003
Trimipramine pharmacokinetics after intravenous and oral administration in carriers of CYP2D6 genotypes predicting poor, extensive and ultrahigh activityJulia Kirchheiner, Johanna Sasse, Ingolf Meineke, et al.Pharmacogenetics|December 4, 2003
ADRIS--The Adverse Drug Reactions Information SchemeHubert Hug, Dario Bagatto, Robert Dannecker, et al.Pharmacogenetics|April 3, 2002
Analysis of the CYP2C19 polymorphism in a North-eastern Thai populationWichittra Tassaneeyakul, Arporn Tawalee, Wongwiwat Tassaneeyakul, et al.Pharmacogenetics|April 3, 2002
N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma riskHarriet Wikman, Päivi Piirilä, Christina Rosenberg, et al.Pharmacogenetics|March 5, 2002
Molecular haplotyping of genomic DNA for multiple single-nucleotide polymorphisms located kilobases apart using long-range polymerase chain reaction and intramolecular ligationOliver G McDonald, Eugene Y Krynetski, William E EvansPharmacogenetics|March 5, 2002
Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomasNaoko Ishibe, Rashmi Sinha, David W Hein, et al.Pharmacogenetics|March 5, 2002
Sequence variation and phylogenetic history of the mouse Ahr geneRussell S Thomas, Sharron G Penn, Kevin Holden, et al.Pageof 83